PetMed Express
Supplies pet medicines and health products directly while extending its pharmacy platform to retail partners.
Something off on this page? Send us feedback.
Profile
PetMeds and PetCareRx sell prescription and non-prescription medicines, food, supplements, supplies, and related pet-health services for dogs, cats, and horses. Direct fulfillment, recurring-order programs, and a white-label retailer arrangement combine consumer e-commerce with licensed-pharmacy infrastructure.
Prescription and non-prescription medicines, food, supplements, supplies, and related pet-health services are sold through the PetMeds and PetCareRx brands for dogs, cats, and horses. Products ship directly to customers through the company's one reportable segment.
Prescription fulfillment requires veterinarian authorization and relies on pharmacy operations licensed in all 50 states. AutoShip and membership programs support recurring orders, while the Rural King agreement brings pharmacy, pharmacist, and e-commerce capabilities to a retailer's channels.
The business depends on its regulated prescription-fulfillment model, continued competitive execution in e-commerce pet pharmacy, and execution of its cost-reduction plan.
Company facts
Key statistics
Year to date −43.0% · Average volume (30d) 101.0K
Analysts
Ratings
Target range
Latest analyst notes
No analyst notes in the last 24 months.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026Q1 FY27 | $0.12 | −$0.28 | −333.3% | $71.0M | $41.0M | −42.2% | −9.85% |
| Jun 2, 2026Q4 FY26 | −$0.18 | −$0.19 | −5.6% | $52.0M | $42.8M | −17.7% | −16.43% |
| Feb 5, 2026Q3 FY26 | −$0.06 | −$0.50 | −733.3% | $54.0M | $40.7M | −24.8% | −3.36% |
| Dec 19, 2025Q2 FY26 | −$0.02 | −$0.34 | −1,600.0% | $69.3M | $44.4M | −36.0% | −2.78% |
Financial highlights
| 12 quarters | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|
| Revenue | $46.5M | $51.2M | $44.4M | $40.7M | $42.8M | $41.0M | |
| Gross profit | $18.9M | $12.1M | $12.4M | $9.5M | $6.8M | $11.3M | |
| Operating income | −$6.0M | −$6.9M | −$8.4M | −$10.5M | −$5.7M | −$6.2M | |
| Net income | −$11.6M | −$34.2M | −$8.5M | −$10.6M | −$4.1M | −$6.1M | |
| Diluted EPS | −$0.56 | −$1.65 | −$0.41 | −$0.50 | −$0.19 | −$0.28 | |
| Gross margin | 40.8% | 23.7% | 28.0% | 23.3% | 16.0% | 27.6% | |
| Operating margin | -13.0% | -13.4% | -18.9% | -25.7% | -13.3% | -15.2% |
Fiscal years (4-quarter sums)FY22 $273.4M · FY23 $256.9M · FY24 $281.1M · FY25 $227.0M · FY26 $179.0M
Revenue by product · FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $13.1M · Total debt $414.0K · Total assets $63.8M · Shareholders' equity $23.0M
Dividends
Raised for 13 straight years.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Aug 11, 2023 | Aug 14 | Aug 18 | $0.30 | |
| Jun 5, 2023 | Jun 6 | Jun 12 | $0.30 | |
| Feb 16, 2023 | Feb 20 | Feb 27 | $0.30 | |
| Nov 17, 2022 | Nov 18 | Nov 30 | $0.30 | |
| Aug 11, 2022 | Aug 12 | Aug 19 | $0.30 | |
| May 19, 2022 | May 20 | May 27 | $0.30 | |
| Feb 4, 2022 | Feb 7 | Feb 18 | $0.30 | |
| Nov 5, 2021 | Nov 8 | Nov 19 | $0.30 |
Ownership
Shares outstanding 21.37M · Float 13.58M · 63.5% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Nina Capital Holdings Inc. · 10 percent owner | 2.60M | 12.17% | Form 4 | Jun 9, 2026 |
| Peter Kennedy | 2.58M | 12.07% | 13D | Jun 29, 2026 |
| Silvercape Investments Ltd · 10 percent owner | 2.58M | 12.07% | Form 4 | Aug 14, 2025 |
| Moises Tache Galante | 2.08M | 10.08% | 13G | Oct 10, 2024 |
| Renaissance Technologies LLC | 1.13M | 5.29% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 8, 2026 | Nina Capital Holdings Inc. | 10 percent owner | +25,000 | $1.75 |
Peers
- Chewy
Online pet pharmacy and Autoship overlap across medicines and supplies
- Petco
Pet-specialty retail and veterinary pharmacy across supplies and prescriptions
- Walmart
Pet pharmacy delivery and omnichannel care overlap in prescriptions and supplies
